Lv71
3340 积分 2024-02-27 加入
Molecular characteristics in Chinese with chronic lymphocytic leukemia by next‐generation sequencing: A single‐center retrospective analysis
3天前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
17天前
已完结
[Expert consensus on combined DNA and RNA next-generation sequencing of common driver genes in solid tumors (2025 version)]
1个月前
已完结
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial
2个月前
已完结
Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2个月前
已完结
Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer
2个月前
已完结
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
3个月前
已完结
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
3个月前
已完结
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
3个月前
已完结
First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial
3个月前
已关闭
皖公网安备34019202002308
